A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer

Figure 4

Assessment of the signature constructed with 7-NRlncRNAs. (a) Univariate Cox regression analysis of clinical characteristics and risk scores. (b) Multivariate Cox regression analysis of clinical characteristics and risk scores. (c) The AUC of 1-year, 3-year, and 5-year survival of risk scores in the entire set. (d) ROC analysis of age, gender, grade, stage, and risk scores in the entire set. (e) A nomogram combining clinicopathological characteristics and risk scores could predict the 1-year, 3-year, and 5-year survival rate of BC patients. (f) The calibration curves showed good consistence between predicted survival and practical outcomes.

(a)

(b)

(c)

(d)

(e)

(f)